Combination therapy in hypertension: An update

Area of Science:

• Cardiology
• Pharmacology

Background:

• Hypertension control is crucial for reducing cardiovascular events, particularly in patients with comorbidities like diabetes mellitus.
• Monotherapy is often insufficient for achieving target blood pressure in most hypertensive patients.
• Multiple factors contribute to hypertension, suggesting combination therapy may be more effective than monotherapy.

Purpose of the Study:

• To review the role and benefits of combination therapy in managing hypertension.
• To discuss various antihypertensive drug classes and their combinations.
• To highlight the importance of individualized treatment strategies based on comorbidities and special populations.

Main Methods:

• Review of recent clinical trials and established antihypertensive drug classes.
• Analysis of fixed-dose combinations versus sequential drug addition.
• Discussion of drug classes including ARBs, diuretics, beta-blockers, calcium antagonists, and ACE inhibitors.

Main Results:

• Combination therapy offers a more effective approach to blood pressure control compared to monotherapy.
• Fixed-dose combinations provide convenience, potentially lower individual drug doses, reduce side effects, and improve compliance.
• Diuretic-based combinations are common, and effective agents include thiazide diuretics, calcium channel blockers, and renin-angiotensin-aldosterone system blockers.

Conclusions:

• Combination antihypertensive therapy is essential for optimal blood pressure control and reduction of cardiovascular endpoints.
• Individualized combination regimens are necessary, considering comorbidities such as diabetes, chronic renal failure, heart failure, and specific populations like the elderly and pregnant women.
• Future strategies should focus on tailored combination therapies for diverse patient profiles to maximize clinical benefits.